title: Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a time.
authors.forename: Paolo
authors.initials: P
authors.lastname: Spagnolo
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Luppi
authors.forename: Toby M
authors.initials: TM
authors.lastname: Maher
authors.forename: Wim A
authors.initials: WA
authors.lastname: Wuyts
authors.forename: Jan C
authors.initials: JC
authors.lastname: Grutters
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D019141:Respiratory System Agents / Q000627:therapeutic use*
chemical_list: D019141:Respiratory System Agents